Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 39, Issue 9, 1996, Pages 1466-1474

  Tsutsumi, Akito ^a   Matsuura, Eiji ^b   Ichikawa, Kenji ^a   Fujisaku, Atsushi ^a   Mukai, Masaya ^a   Kobayashi, Seiichi ^a   Koike, Takao ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b YAMASA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT;

ARTICLE; CLINICAL FEATURE; FETUS WASTAGE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

EID: 0029790008     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390905     Document Type: Article

References (32)

1. Asherson RA, Cervcra R: Anticardiolipin antibodies, chronic biologic false-positive tests for syphilis and other antiphospholipid antibodies. In, Dubois' Lupus Erythematosus. Fourth edition. Philadelphia, Lea and Febiger, 1993
2. Hughes GRV: The antiphospholipid antibody syndrome: 10 years on. Lancet 342:341-344, 1993
3. McNeil HP, Chesterman CN, Krilis SA: Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 49:193-280, 1990
4. Koike T, Sueishi M, Funaki H, Tomioka H, Yoshida S: Antiphospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol 56:193-199, 1984
5. Lockshin MD, Druzin ML, Goei S, Qamar T, Magid MS, Jovanovic L, Ferenc M: Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 313:152-156, 1985
6. Hamsten A, Norberg R, Bjorkholm M, de Faire V, Holm G: Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet 1:113-116, 1986
7. Harris EN, Chan JKH, Asherson RA, Aber VR, Gharavi AE, Hughes GRV: Thrombosis, recurrent fetal loss, and thrombocytopenia: predictive value of the anticardiolipin antibody test. Arch Intern Med 146:2153-2156, 1986
8. Fort JG, Cowchock FS, Abruzzo JL, Smith JB: Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum 30:752-760, 1987
9. Kalunian KC, Peter JB, Middlekauff HR, Sayre J, Ando DG, Mangotich M, Hahn BH: Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med 85:602-608, 1988
10. Shergy WJ, Kredich DW, Pisetsky DS: The relationship of anti-cardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus. J Rheumatol 15:1389-1394, 1988
11. Weidmann CE, Wallace DJ, Peter JB, Knight PJ, Bear MB, Klinenberg JR: Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. J Rheumatol 15:75-79,1988
12. Shimada K, Koike T, Ichikawa K, Tsutsumi A, Takabayashi K, Tomioka H, Yoshida S: IgG class anticardiolipin antibody as a possible marker for evaluating fetal risk in patients with systemic lupus erythematosus. J Autoimmun 2:843-849, 1989
13. Asherson RA, Khamashta MA, Gil A, Vazquez JJ, Chan O, Baguley E, Hughes GRV: Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 86:391-399, 1989
14. Alarcon-Segovia D, Deleze M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J, Fernandez L, Ponce de Leon S: Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective study of 500 consecutive patients. Medicine (Baltimore) 68:353-365, 1989
15. Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE disorders. Ann Intern Med 112:682-698, 1990
16. Castenon C, Amigo M, Banales JL, Nava A, Reyes PA: Ocular vasoocculusive disease in primary antiphospholipid syndrome. Ophthalmology 102:256-262, 1995
17. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 87:4120-4124, 1990
18. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda Vriesman PJ, Barbui T, Zwaal RF, Bavers EM: Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma cofactor. Lancet 335:1544-1547, 1990
19. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T: Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336:177-178, 1990
20. Koike T, Matsuura E: What is the "true" antigen for anticardiolipin antibodies? Lancet 337:671-672, 1991
21. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Suzuki T, Sumida T, Yasuda T, Koike T: Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 148:3885-3891, 1992
22. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179:457-462, 1994
23. Koike T, Tsutsumi A, Ichikawa K, Matsuura E: Antigenic specificity of the "anticardiolipin" antibodies (letter). Blood 85:2277-2278, 1995
24. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
25. Schleider MA, Nachman RL, Jaffe EA, Coleman M: A clinical study of the lupus anticoagulant. Blood 48:499-509, 1976
26. 2-glycoprotein I in the absence of phospholipid: importance of Ag density and bivalent binding. J Immunol 154:954-960, 1995
27. Oosting JD, Derksen RHWM, Bobbink IWG, Hackeng TM, Bouma BN, de Groot PG: Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood 81:2618-2625, 1993
28. 2-Glycoprotein I in the expression of lupus anticoagulant activity. Blood 83:2878-2892, 1994
29. Farrugia E, Torres VE, Gastinaeu D, Michet CJ, Holley KE: Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study. Am J Kidney Dis 20:463-471, 1992
30. Green D, Hougie C, Kazmier FJ, Lechner K, Mannucci PM, Rizza CR, Sultan Y: Report of the working party on acquired inhibitors of coagulation: studies of the "lupus" anticoagulant. Thromb Haemost 49:144-146, 1983
31. Colaco CB, Elkon KB: The lupus anticoagulant: a disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA. Arthritis Rheum 28:67-74, 1985
32. Feinstein DI, Francis RB: The lupus anticoagulant. In, Dubois' Lupus Erythematosus. Fourth edition. Philadelphia, Lea and Febiger, 1993